Zentalis Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference
May 28, 2020 16:05 ET
|
ZENTALIS PHARMACEUTICALS
NEW YORK and SAN DIEGO, May 28, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on developing clinically differentiated,...
Zentalis Pharmaceuticals and Tavros Therapeutics Announce Strategic Platform Collaboration to Discover Next Generation Targeted Small Molecule Therapies
May 28, 2020 07:00 ET
|
ZENTALIS PHARMACEUTICALS
NEW YORK, SAN DIEGO and DURHAM, N.C., May 28, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL) and Tavros Therapeutics, Inc., today announced a strategic collaboration to apply...
Zentalis Pharmaceuticals宣布成立中国合资企业Zentera Therapeutics，并获得2000万美元的A轮融资
May 20, 2020 07:00 ET
|
ZENTALIS PHARMACEUTICALS
纽约和圣地亚哥, May 20, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals，Inc.（纳斯达克代码：ZNTL），是一家临床阶段的生物制药公司，致力于发现和开发针对癌症基本生物学途径的小分子疗法。Zentalis今日宣布完成Zentera Therapeutics的2000万美元A轮融资。Zentara...
Zentalis Pharmaceuticals Announces $20 Million Series A Financing to Establish a Chinese Joint Venture, Zentera Therapeutics
May 20, 2020 07:00 ET
|
ZENTALIS PHARMACEUTICALS
NEW YORK and SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small...
Zentalis Pharmaceuticals Announces $20 Million Series A Financing to Establish a Chinese Joint Venture, Zentera Therapeutics
May 20, 2020 07:00 ET
|
ZENTALIS PHARMACEUTICALS
NEW YORK and SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small...
Zentalis Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Update
May 15, 2020 07:00 ET
|
ZENTALIS PHARMACEUTICALS
Completed initial public offering of common stock, raising approximately $190.0 million in gross proceeds Fourth oncology Investigational New Drug (IND) application cleared by FDA for ZN-d5, a BCL-2...
Zentalis Pharmaceuticals Announces FDA Clearance of IND Application for ZN-d5 for the Treatment of Hematologic Malignancies
April 30, 2020 07:00 ET
|
ZENTALIS PHARMACEUTICALS
NEW YORK and SAN DIEGO, April 30, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small...
Zentalis Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 07, 2020 16:05 ET
|
ZENTALIS PHARMACEUTICALS
NEW YORK and SAN DIEGO, April 07, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small...
Zentalis Pharmaceuticals Announces Pricing of Initial Public Offering
April 02, 2020 21:22 ET
|
ZENTALIS PHARMACEUTICALS
NEW YORK and SAN DIEGO, April 02, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small...